A fluorescent compound, kit and preparation method for dsDNA quantification
By optimizing the substitution position of the cationic side chain with a single-methyl asymmetric cyanine dye, the sensitivity and specificity of dsDNA quantification have been improved, overcoming the shortcomings of existing fluorescent dye methods. This has achieved high accuracy and impurity resistance in dsDNA quantification, reaching the same level as imported products.
Patent Information
- Application Number
- CN202311004123.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-08-10
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2043-08-10
AI Technical Summary
Existing fluorescent dye methods for dsDNA quantification suffer from insufficient sensitivity, accuracy, and specificity, and are sensitive to dye binding rate and impurities, affecting detection accuracy.
A kit for dsDNA quantification was prepared by using monomethyl asymmetric cyanine dyes and optimizing the substitution positions of the cationic side chains to improve the specificity, sensitivity, and impurity resistance of fluorescent compounds.
It achieves high sensitivity, accuracy and specificity in dsDNA quantification, reduces fluorescence background, is comparable to commercially available imported products at both low and high concentrations, and has good tolerance to common pollutants.
Smart Images

Figure CN117164577B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of fluorescent compounds, and in particular to a fluorescent compound for dsDNA quantification, a kit and a preparation method. Background Art
[0002] In many fields, the detection or quantification of nucleic acids is useful or necessary, such as in biology, biomedicine, genetics, fermentation, aquaculture, agriculture, forensics and environmental research. The nucleic acid quantification methods currently used include ultraviolet spectrophotometry: a method for quantitatively and qualitatively analyzing nucleic acids based on the principle that purine bases and pyrimidine bases in nucleic acids have conjugated double bonds and have a maximum absorption peak at 260nm under ultraviolet light. It is a commonly used method in the laboratory; fluorescent dye method: based on the principle that fluorescent dyes bind to nucleic acid molecules and emit a fluorescent signal whose intensity is proportional to the number of nucleic acid molecules bound. Commonly used fluorescent dyes include ethidium bromide, SYBR series dyes, etc.; real-time fluorescence quantitative PCR method: adding fluorescent groups to the reaction system, accumulating fluorescent signals emitted by the fluorescent groups to detect the PCR reaction process in real time, and finally quantitatively analyzing the unknown concentration of nucleic acids by relative or absolute quantitative methods. Commonly used detection methods include TaqMan probes and fluorescent dyes.
[0003] Among the several nucleic acid quantification methods mentioned above, the fluorescent dye method is widely used due to its high sensitivity and repeatability, as well as its ease of operation and low cost. However, the detection results of the fluorescent dye method are affected by the binding rate of the dye to the nucleic acid. For some high-precision application scenarios, it is necessary to improve the accuracy and specificity of its detection. In addition, the dyes are generally highly toxic, and for some application scenarios, it is also necessary to consider reducing the impact of the dyes on the subsequent detection and analysis process. Therefore, the innovation of the molecular structure of fluorescent dyes has always been a hot spot in the research and development of this type of product.
[0004] Next-generation sequencing workflows require good library construction to provide successful results in massively parallel sequencing strategies. Requirements for a good DNA library include the following: The multiple double-stranded nucleic acids generated in the preparatory steps of the workflow have a pre-selected length range, including primer and adapter sequences, and must be quantified enough to determine effective library loading into the sequencing step. NGS library quantification requires higher sensitivity, accuracy, and specificity for nucleic acid quantification than other application scenarios. The core technology to improve the sensitivity, accuracy, and specificity of nucleic acid quantification using fluorescent dyes is the structure of fluorescent dyes.
[0005] The dye structures that are currently being studied include dyes with polymethine structures. This type of dye is a linear conjugated system with an odd number of methine groups, in which the terminal heteroatoms N, O or S are ultimately contained in two terminal heterocycles. Previous studies have found that many monomethine dyes are known, and some monomethine dyes have the characteristics of no fluorescence or minimal fluorescence in buffer or in the presence of single-stranded DNA or RNA, but have strong fluorescence in the presence of double-stranded DNA. Therefore, many fluorescent dyes for dsDNA quantification have been extensively studied based on the monomethine structure, mainly involving the substituted modified side chain structure in the two terminal heterocycles. Different side chain structure modifications will affect the spectral properties of the dye, and there are differences in the specificity and sensitivity of dsDNA quantification. Therefore, by optimizing the molecular structure of fluorescent compounds, improving the sensitivity, specificity, and stability of dsDNA quantification, and reducing the fluorescence background, it is of great significance to improve the application performance of dsDNA quantification products and broaden their application scenarios and market prospects. Summary of the invention
[0006] One of the purposes of the present invention is to provide a fluorescent compound that can be used as a dye for nucleic acid quantification by a fluorescent dye method, thereby improving the specificity and sensitivity of dsDNA quantification, reducing the fluorescence background value, and improving the detection accuracy.
[0007] A second object of the present invention is to provide a method for preparing a fluorescent compound.
[0008] At the same time, the present invention also provides a dsDNA quantification kit.
[0009] In order to achieve the above object, the technical solution adopted by the present invention is as follows:
[0010] A fluorescent compound for dsDNA quantification, the general chemical structure of which is shown in formula (I):
[0011]
[0012] Wherein R1 and R2 are cationic side chains, and the structures of R1 and R2 are the same or different;
[0013] R3 and R4 are H or an alkyl or substituted alkyl group having 1 to 4 carbon atoms.
[0014] Furthermore, the general chemical structure of R1 is: Wherein A is the parent ring structure of the fluorescent compound as shown in (I); R5 is H or an alkyl or substituted alkyl group with 1 to 4 carbon atoms.
[0015] More preferably, the R5 is methyl.
[0016] Optionally, the chemical structure of R2 is wherein n=any integer from 2 to 4; wherein A is the parent ring structure of the fluorescent compound as shown in (I). Further preferably, n=4.
[0017] Preferably, R3 and R4 are H.
[0018] The method for preparing the fluorescent compound for dsDNA quantification comprises preparing the compound represented by formula (i), formula (ii), formula (iii) and formula (iv) as raw materials:
[0019]
[0020] A dsDNA quantification kit comprises a dilution buffer, a dsDNA quantification standard reagent and a dsDNA quantification dye reagent; wherein the fluorescent compound component in the dsDNA quantification dye reagent is the above-mentioned fluorescent compound.
[0021] In a specific embodiment of the present invention, the dilution buffer is TE buffer; the dsDNA quantification standard reagent is TE buffer containing 10 ng / μl dsDNA standard; and the dsDNA quantification dye reagent is prepared by dissolving a fluorescent compound in a DMSO solvent.
[0022] The fluorescent compound provided by the present invention belongs to a monomethine asymmetric cyanine dye. Before the present invention was proposed, this type of dye had been commercially applied to dsDNA quantification. Different companies have different substitution structure improvements on this type of dye, and there are differences in the specificity, sensitivity, accuracy and impurity resistance of dsDNA quantification. The fluorescent compound provided by the present invention improves the specificity, sensitivity, accuracy and impurity resistance of the fluorescent compound applied to dsDNA quantification by optimizing the substitution position of the cationic side chain, achieving an application effect equal to or better than that of imported products with better performance on the market, and realizing domestic substitution.
[0023] Through experiments and verification, the kit for dsDNA quantification provided by the present invention has excellent sensitivity, accuracy and specificity for dsDNA quantification. In low-concentration (0.1-1.2 ng / uL) and high-concentration (90-120 ng / uL) application scenarios, the sensitivity and accuracy are equivalent to those of imported similar products; in the detection of λDNA, RNA, and λDNA+RNA (1:1), the RNA binding ability is very weak; in the detection of conventional pollutants, it has good tolerance to some conventional pollutants, such as salts, free nucleotides, proteins, solvents, detergents, etc., has the same impurity resistance as the Thermo Fisher Qubit kit, and is superior to other commercially available fluorescent compounds with the same function. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 Thermo Fisher Scientific QubitTM Schematic diagram of the dsDNA binding specificity detection results of 1X dsDNA High Sensitivity Quantitation Kit for DNA, RNA, and DNA samples containing RNA;
[0025] Figure 2 A schematic diagram of the detection results of the dsDNA binding specificity of the kit composed of fluorescent compounds provided in Example 1 to DNA, RNA, and DNA samples containing RNA;
[0026] Figure 3 A schematic diagram of the detection results of the dsDNA binding specificity of the kit composed of fluorescent compounds provided in Example 2 to DNA, RNA, and DNA samples containing RNA;
[0027] Figure 4 A schematic diagram of the detection results of the dsDNA binding specificity of the kit composed of fluorescent compounds provided in Example 3 to DNA, RNA, and DNA samples containing RNA;
[0028] Figure 5 A schematic diagram of the detection results of the dsDNA binding specificity of the kit composed of fluorescent compounds provided in Comparative Example 1 to DNA, RNA, and DNA samples containing RNA;
[0029] Figure 6 A schematic diagram of the detection results of the dsDNA binding specificity of the kit composed of fluorescent compounds provided in Comparative Example 2 to DNA, RNA, and DNA samples containing RNA;
[0030] Figure 7 A schematic diagram of the detection results of the dsDNA binding specificity of the kit composed of fluorescent compounds provided in Comparative Example 3 to DNA, RNA, and DNA samples containing RNA;
[0031] Figure 8 This is a schematic diagram of the specificity test results of the Helixyte kit for dsDNA binding to DNA, RNA, and DNA samples containing RNA;
[0032] Fig. 9 A schematic diagram of the specificity detection results of the Picogreen kit for DNA, RNA, and dsDNA binding to RNA-containing DNA samples;
[0033] Fig.10 Schematic diagram of the results of specific detection of dsDNA binding of DNA, RNA, and RNA-containing DNA samples by a kit composed of SYBR Green. DETAILED DESCRIPTION
[0034] definition:
[0035] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
[0036] The present invention will be further described below in conjunction with specific embodiments, but the embodiments do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art. Unless otherwise specified, the reagents and materials used in the following examples are commercially available.
[0037] The present invention provides a fluorescent compound for dsDNA quantification, and its chemical structure is shown in formula (I):
[0038]
[0039] Wherein R1 and R2 are cationic side chains, and the structures of R1 and R2 are the same or different;
[0040] R3 and R4 are H or an alkyl or substituted alkyl group having 1 to 4 carbon atoms.
[0041] The fluorescent compound of the present invention is an asymmetric cyanine fluorophore, containing two aromatic ring groups, which are connected by an unsaturated hydrocarbon chain containing a methine group; wherein the first aromatic ring group is benzothiazole, and the heteroatom is S; the second aromatic ring group is quinoline, wherein a benzene ring substituent is connected to the N atom, and cationic side chain structures are respectively connected to the two fused aromatic rings; wherein the chemical structures of the cationic side chains at the two positions may be the same or different, and as a preferred embodiment, the general structure of R1 is R5 is H or an alkyl or substituted alkyl group with 1 to 4 carbon atoms: The general structure of R2 is
[0042] The fluorescent compounds of the following examples and comparative examples of the present invention are preferably synthesized from iodoalkylcyanine starting materials prepared according to methods known in the art.
[0043] The following uses a fluorescent compound with a specific structure as an example to characterize and verify the application effect of the fluorescent compound of the present invention in dsDNA quantification:
[0044] Example 1
[0045] This embodiment provides a fluorescent compound for dsDNA quantification, and its chemical structure is shown in formula (II):
[0046]
[0047] It is prepared from materials shown in formula (i-1), (ii-1), (iii-1), and (iv-1):
[0048]
[0049] The specific operation and reaction process are as follows:
[0050] 1) Weigh formula (i-1), copper powder, potassium carbonate and formula (ii-1) in a three-necked flask and heat under reflux for 48 hours. After the reaction is completed, cool to room temperature, add water and ethyl acetate for extraction, collect the organic phase, and dry it over anhydrous sodium sulfate. The crude organic phase product is dry-loaded, purified and separated using a silica gel column, and petroleum ether / ethyl acetate system is used as the mobile phase for purification to obtain intermediate product 1, and its process synthesis route is:
[0051]
[0052] 2) Weigh the intermediate product 1 and dissolve it in dichloromethane. Then add phosphorus oxychloride and a catalytic amount of N,N-dimethylformamide in sequence, and heat the mixture under reflux for 24 hours. After the reaction is completed, cool it to room temperature, and the obtained reaction solution is directly used for the next step of reaction;
[0053]
[0054] 3) Add 3-methyl-2-(methylthio)benzothiazolium p-toluenesulfonate (the compound shown in formula (III-1)) to the reaction solution obtained in step 2), and then add triethylamine, and stir the mixture at room temperature for 6 hours to complete the reaction; the mixture is purified on silica gel using dichloromethane / methanol mobile phase to obtain intermediate 2.
[0055]
[0056] 4) Add dichloromethane to the intermediate product 2 to dissolve it, and then add N,N-dimethyl-1,3-diaminopropane (the compound represented by formula (ⅳ-1)), and react at 55°C for 2 hours. After the reaction is completed, the mixture is purified using C18 reverse silica gel to obtain the target compound.
[0057]
[0058] Example 2
[0059] This embodiment provides a fluorescent compound for dsDNA quantification, and its chemical structure is shown in formula (III):
[0060]
[0061] The same method as Example 1 was used to prepare it.
[0062] Example 3
[0063] This embodiment provides a fluorescent compound for dsDNA quantification, and its chemical structure is shown in formula (IV):
[0064]
[0065] The same method as Example 1 was used to prepare it.
[0066] Comparative Example 1
[0067] This comparative example provides a fluorescent compound for dsDNA quantification, and its chemical structure is shown in formula (V):
[0068]
[0069] The same method as Example 1 was used to prepare it.
[0070] Comparative Example 2
[0071] This comparative example provides a fluorescent compound for dsDNA quantification, and its chemical structure is shown in formula (VI):
[0072]
[0073] The same method as Example 1 was used to prepare it.
[0074] Comparative Example 3
[0075] This comparative example provides a fluorescent compound for dsDNA quantification, and its chemical structure is shown in formula (VII):
[0076]
[0077] The same method as Example 1 was used to prepare it.
[0078] ①Test example
[0079] 1. Material preparation:
[0080] A: Self-assembly kit:
[0081] Buffer: Thermo Fisher Qubit TM 1X TE buffer from the dsDNA quantification kit;
[0082] Standard: TE buffer containing 10 ng / uL λDNA;
[0083] Detection working solution: Take the same mass of Examples 1 to 3, Comparative Examples 1 to 3, Picogreen (BaiSai Biotech: P202), SYBR Green (Thermo Fisher: S7567), and Helixyte fluorescent compound (Avidin: 17591), respectively, dissolve them in DMSO solvent, and prepare a 1 mg / ml detection working solution;
[0084] B: Commercially available kit: Thermo Fisher Qubit TM 1X dsDNA Quantification Kit
[0085] 2. Detection of the application effect of dsDNA quantification:
[0086] 1) Sensitivity detection:
[0087] The dsDNA sample (λDNA) was diluted into a series of concentrations, and quantitative detection was performed using the detection working solutions configured by Examples 1 to 3, Comparative Examples 1 to 3, Helixyte, Picogreen, and SYBR Green, and the kits assembled with buffer and standard substances. The quantitative results of the Thermo Fisher Qubit kit were used as the standard value, and the differences in the accuracy and sensitivity of dsDNA quantification of different detection working solutions at low concentrations (0.1-1.2 ng / uL) and high concentrations (90-120 ng / uL) were compared. The results are shown in Tables 1, 2, and 3:
[0088] Table 1: λDNA determination values of Examples 1-3 and Comparative Examples 1-3 and Thermo Fisher Qubit TM Ratio of the values measured by 1X dsDNA Quantification Kit (low concentration):
[0089]
[0090]
[0091] Table 2: Example 1, λDNA determination values of Helixyte, picogreen, SYBR Green and Thermo Fisher Scientific Qubit TM Ratio of the values measured by 1X dsDNA Quantification Kit (low concentration):
[0092]
[0093] Table 3: λDNA determination values of Examples 1-3 and Comparative Examples 1-3 and Thermo Fisher Qubit TM Ratio of the values measured by 1X dsDNA Quantification Kit (high concentration):
[0094]
[0095] Table 4: Example 1, Helixyte, picogreen, SYBR Green and Thermo Fisher Qubit TM Ratio of the values measured by 1X dsDNA Quantification Kit (high concentration):
[0096]
[0097] The data results shown in Tables 1, 2 and 3 above show that the fluorescent compound provided by the present invention has higher quantitative accuracy and sensitivity for low-concentration dsDNA (0.1-1.2 ng / uL), and can also accurately quantify high-concentration dsDNA (90-120 ng / uL). Its performance is better than that of the Thermo Fisher Qubit TM The 1X dsDNA quantification kit is comparable to and superior to the fluorescent compounds provided in Comparative Examples 1 to 3 and other commercially available fluorescent compounds.
[0098] 2) Specificity detection:
[0099] A kit assembled using the detection working solution and buffer and standard substance configured with Examples 1 to 3, Comparative Examples 1 to 3, Helixyte, Picogreen, and SYBR Green, and the Thermo Fisher Qubit TM The 1X dsDNA High Sensitivity Quantification Kit was used to quantify λDNA, MS2RNA, and λDNA+MS2RNA (1:1). The three samples were diluted into a series of concentrations to determine the binding specificity of different fluorescent compounds to DNA, RNA, and DNA samples containing RNA. The results are shown in Figure 2. Figures 1 to 10 As shown, it is shown that the fluorescent compound provided by the present invention and other commercially available fluorescent compounds have good dsDNA binding specificity, which is better than Comparative Example 1 and Comparative Example 3.
[0100] C: Test of tolerance to conventional pollutants:
[0101] The kits were assembled using the working solutions of Examples 1 to 3, Comparative Examples 1 to 3, Helixyte, Picogreen, SYBR Green, buffer solutions and standards, and the Thermo Fisher Qubit TM 1X dsDNA High Sensitivity Quantification Kit uses fluorescence to quantify specific concentrations of NaCl, MgCl2, NH4AC, ethanol, phenol, SDS, Triton X-100, dNTP, BSA, and ssDNA. Add the final concentration of the pollutants corresponding to the table below into the dsDNA detection system, use a fluorescence quantification instrument to measure dsDNA, compare the detection values of different fluorescent dyes combined with dsDNA, and determine the tolerance to pollutants. The judgment criteria are: TMThe 1X dsDNA High Sensitivity Quantitation Kit is used as the benchmark. Other kits whose nucleic acid quantitation results differ from Thermo Fisher's nucleic acid quantitation results by more than 10% after adding corresponding impurities are defined as not having impurity tolerance and the judgment result is ×. The results are shown in Table 5 below:
[0102] Table 5
[0103]
[0104]
[0105] The results shown in Table 5 above indicate that, compared with Comparative Examples 1 to 3 and other commercially available fluorescent compounds, the fluorescent compound provided by the present invention has better impurity tolerance when applied to dsDNA quantification.
[0106] Overall conclusion: The present invention conducts comparative detection and analysis on the actual application effects of fluorescent compounds with different chemical structures and commercially available kits in dsDNA quantification. The results show that the fluorescent compounds provided by the present invention are highly selective for double-stranded DNA when applied to dsDNA quantification. Compared with other commercially available fluorescent compounds, they have higher sensitivity and accuracy in low-concentration and high-concentration application scenarios. In addition, they have good tolerance to some common pollutants, such as salts, free nucleotides, proteins, solvents, detergents, etc., and have equivalent performance effects to equivalent products of Thermo Fisher in terms of functionality, and can achieve domestic substitution of imported products.
[0107] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A fluorescent compound for dsDNA quantification, characterized in that: Its chemical structure is shown in formula (I): Wherein R1 and R2 are cationic side chains, and the structures of R1 and R2 are the same or different; R3 and R4 are H or an alkyl group of 1 to 4 carbons; The general chemical structure of R1 is: R5 is H or an alkyl group of 1 to 4 carbons; R2 is Where n=2 or 3.
2. The fluorescent compound for dsDNA quantification according to claim 1, characterized in that: The R5 is a methyl group.
3. The fluorescent compound for dsDNA quantification according to claim 2, characterized in that: n=3。 4. The fluorescent compound for dsDNA quantification according to any one of claims 1 to 3, characterized in that The R3 and R4 are H.
5. A method for preparing a fluorescent compound for dsDNA quantification according to any one of claims 1 to 4, characterized in that: The method is prepared by using compounds represented by formula (i), formula (ii), formula (iii) and formula (iv) as raw materials:
6. A kit for quantifying dsDNA, characterized in that: The invention comprises a dilution buffer, a standard reagent for dsDNA quantification, and a dye reagent for dsDNA quantification; wherein the fluorescent compound component in the dye reagent for dsDNA quantification is the fluorescent compound as claimed in any one of claims 1 to 4.
7. The kit for quantifying dsDNA according to claim 6, wherein The dilution buffer is TE buffer; the dsDNA quantitative standard reagent is TE buffer containing 10 ng / μl dsDNA standard; the dsDNA quantitative dye reagent is prepared by dissolving a fluorescent compound in a DMSO solvent.
